Paul Chaplin
Chief Executive Officer bei BAVARIAN NORDIC A/S
Aktive Positionen von Paul Chaplin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BAVARIAN NORDIC A/S | Chief Executive Officer | 28.05.2014 | - |
President | 28.05.2014 | - | |
Chief Tech/Sci/R&D Officer | 01.01.2004 | 10.02.2012 | |
Corporate Officer/Principal | 10.02.2012 | 28.05.2014 | |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Corporate Officer/Principal | 03.03.2011 | - |
Bavarian Nordic, Inc.
Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | President | - | - |
Karriereverlauf von Paul Chaplin
Ausbildung von Paul Chaplin
University of Bristol | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 2 |
Dänemark | 2 |
Vereinigtes Königreich | 2 |
Operativ
Corporate Officer/Principal | 2 |
President | 2 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BAVARIAN NORDIC A/S | Health Technology |
Private Unternehmen | 2 |
---|---|
Bavarian Nordic, Inc.
Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | Commercial Services |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Health Technology |
- Börse
- Insiders
- Paul Chaplin
- Erfahrung